Stephanie is a life-sciences professional with enthusiasm for invention, technology transfer and commercialisation. She co-directs translational activities for academic discovery and innovation for Medicine at Imperial College London, including industrial collaborations and technology licensing. The ultimate goal is for market adoption of health and wellbeing technologies that have real-world impact.
Stephanie joined Imperial in 2018, having worked within start-ups, SMEs and large multinational pharmaceutical organisations across Australia and UK. She has a unique breadth of experience across the full care continuum, including academia, R&D, clinical development, commercialisation, as well as working with patients in both acute and chronic care settings in the community.
Stephanie holds tertiary qualifications in both biomedical science and in business, a Master’s in Business Administration (MBA), is a Certified Licensing Professional (CLP) and a graduate of the Australian Institute of Company Directors (AICD).